Found: 28
Select item for more details and to access through your institution.
Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 3058, doi. 10.3390/cancers15113058
- By:
- Publication type:
- Article
Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2699, doi. 10.3390/cancers15102699
- By:
- Publication type:
- Article
Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 430, doi. 10.3390/cancers15020430
- By:
- Publication type:
- Article
Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2516, doi. 10.3390/cancers14102516
- By:
- Publication type:
- Article
BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 581, doi. 10.3390/cancers13030581
- By:
- Publication type:
- Article
(2 R ,3 S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2842, doi. 10.3390/cancers12102842
- By:
- Publication type:
- Article
Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1779, doi. 10.3390/cancers11111779
- By:
- Publication type:
- Article
Autologous Transplantation for Older Adults with AML.
- Published in:
- Cancers, 2018, v. 10, n. 9, p. 340, doi. 10.3390/cancers10090340
- By:
- Publication type:
- Article
The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid Leukemia.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 170, doi. 10.3390/cancers10060170
- By:
- Publication type:
- Article
Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma.
- Published in:
- Turkish Journal of Hematology, 2023, v. 40, n. 3, p. 187, doi. 10.4274/tjh.galenos.2023.2023.0136
- By:
- Publication type:
- Article
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 17, p. 2747, doi. 10.3390/cells11172747
- By:
- Publication type:
- Article
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia.
- Published in:
- Biomedicines, 2024, v. 13, n. 7, p. 1616, doi. 10.3390/biomedicines12071616
- By:
- Publication type:
- Article
Huwe1-Mediated Ubiquitylation of Dishevelled Defines a Negative Feedback Loop in the Wnt Signaling Pathway.
- Published in:
- Science Signaling, 2014, v. 7, n. 317, p. 1, doi. 10.1126/scisignal.2004985
- By:
- Publication type:
- Article
Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10824-3
- By:
- Publication type:
- Article
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma.
- Published in:
- Current Oncology, 2023, v. 30, n. 12, p. 10463, doi. 10.3390/curroncol30120762
- By:
- Publication type:
- Article
Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 2, p. 268, doi. 10.1111/bjh.13118
- By:
- Publication type:
- Article
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2378, doi. 10.3390/jcm12062378
- By:
- Publication type:
- Article
Rising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma.
- Published in:
- Current Issues in Molecular Biology, 2024, v. 46, n. 8, p. 8197, doi. 10.3390/cimb46080484
- By:
- Publication type:
- Article
FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia.
- Published in:
- Current Issues in Molecular Biology, 2024, v. 46, n. 4, p. 2946, doi. 10.3390/cimb46040184
- By:
- Publication type:
- Article
A Minimal Transcription Activation Domain Consisting of a Specific Array of Aspartic Acid and Leucine Residues.
- Published in:
- Biological Chemistry, 1994, v. 375, n. 7, p. 463
- By:
- Publication type:
- Article
Different Potential of Cellular and Viral Activators of Transcription Revealed in Oocytes and Early Embryos of Xenopus laevis.
- Published in:
- Biological Chemistry, 1994, v. 375, n. 2, p. 105
- By:
- Publication type:
- Article
Basic leucine zipper transcription factors C/EBP and MafL in the hydrozoan jellyfish Podocoryne carnea.
- Published in:
- Developmental Dynamics, 2004, v. 230, n. 3, p. 392
- By:
- Publication type:
- Article
Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Basal components of the transcription apparatus (RNA polymerase II, TATA -binding protein) contain activation domains: Is the repetitive c-terminal domain (CTD) of RNA polymerase II a 'Portable Enhance Domain'?
- Published in:
- Molecular Reproduction & Development, 1994, v. 39, n. 2, p. 215, doi. 10.1002/mrd.1080390215
- By:
- Publication type:
- Article
Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 15, p. 8092, doi. 10.3390/ijms22158092
- By:
- Publication type:
- Article
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5688, doi. 10.3390/ijms24065688
- By:
- Publication type:
- Article
Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12587, doi. 10.3390/ijms232012587
- By:
- Publication type:
- Article